274:(born August 25, 1969) is an American human geneticist and entrepreneur who works in personalized medicine. Stephan is currently CEO of NeuBase Therapeutics and a General Partner in Cyto Ventures. Before NeuBase, Stephan was CEO of LifeX and Chairman and Professor of Human Genetics at the University of Pittsburgh. Prior, he was founding Chairman of the Neurogenomics Division at the Translational Genomics Research Institute. Stephan has founded or co-founded 14 biotechnology companies and advised many others. Stephan was co-founder of
124:
481:
292:
66:
25:
425:(TGen) as a Senior Investigator and founding Chairman of the Department of Neurogenomics. He later served as the Deputy Director of Discovery Research at TGen. His laboratory has identified the genetic basis of 20 single gene disorders, and several dozen complex genetic disorders using high-throughput technologies and strategies, many if which were developed by his team
595:
In
January 2007, bases on a publication from his group in Science, he co-founded Amnestix, a pharmaceutical company that focuses on the treatment of learning and memory impairment, acquired by Sygnis AG. In 2009, together with Vern Norviel, he co-founded Aueon, Inc., a biotechnology company that
443:
Stephan led the
Population Genetics and Translational Acceleration effort at the Personalized Medicine Institute, a joint initiative between the University of Pittsburgh Schools of Health Sciences and UPMC, the largest integrated health system in the US. He held faculty positions at the Children's
205:
466:
He served as the
Chairman of the NIH Neuroscience Microarray Consortium for seven years. This was at the time the highest volume genome scanning infrastructure in the world, performing the International Autism Genome Project and the largest study in ALS (Lou Gehrig's Disease), among others.
431:
He has also implemented personalized genomic medicine clinical programs with sustainable business models. Stephan crafted the business case and obtained the initial funding for the Gene
Partnership Project at
649:
602:
In 2014, he helped found
Pendulum therapeutics and served at its Chairman of the Board until 2018. Stephan has served at Chairman of the Board of Peptilogics, a rational
631:
772:
676:
777:
596:
invented and patented tumor sequencing and targeted therapeutic selection for cancer patients which is now emerging as the standard of care in oncology.
489:
320:
300:
422:
782:
415:
653:
80:
76:
428:
He served as tenured full professor and
Chairman of the Department of Human Genetics at the University of Pittsburgh from 2013 to 2018.
737:
140:
571:
393:
180:
162:
52:
38:
742:
133:
447:
Stephan has published more than 150 peer-reviewed scientific articles in the scientific literature, in top tier journals such as
98:
87:
552:
374:
524:
346:
767:
433:
505:
324:
316:
531:
353:
719:
599:
In 2011, he founded a next-generation genome sequencing and interpretation company, Lifecode (acquired by MedGenome).
494:
305:
407:
538:
498:
360:
309:
673:
411:
228:
693:
520:
342:
632:"Gene silencing company NeuBase Therapeutics to reverse merge its way onto Nasdaq via troubled microcap Ohr"
792:
437:
144:
44:
787:
603:
204:
592:, which was among the first direct-to-consumer genomics company (acquired by Life Technologies).
331:
610:
545:
367:
680:
609:
In 2019, he founded NeuBase
Therapeutics, a biotechnology company focused on developing
139:
It may require cleanup to comply with
Knowledge (XXG)'s content policies, particularly
761:
243:
232:
508:. Contentious material about living people that is unsourced or poorly sourced
694:"File Not Found (404) – AAAS - The World's Largest General Scientific Society"
589:
585:
275:
262:
724:
674:
http://www.navigenics.com/visitor/about_us/team/executives/dietrich_stephan/
650:"Dietrich Stephan, CEO and Founder of LifeX™ — Life Sciences Pittsburgh"
697:
474:
330:
from the article and its talk page, especially if potentially
285:
117:
59:
18:
747:
752:
588:, a personal genetics testing company, with oncologist
94:
720:"Human genes made to fit on a chip the size of a dime"
444:
National
Medical Center and Johns Hopkins University.
132:
A major contributor to this article appears to have a
265:, Amnestix, Aueon, Pendulum Therapeutics, Peptilogics
410:and his Ph.D. in Human Molecular Genetics from the
257:
249:
239:
211:
195:
461:Proceedings of the National Academy of Sciences
8:
261:Founder/co-Founder of NeuBase Therapeutics,
406:Stephan received his B.Sc. in Biology from
53:Learn how and when to remove these messages
323:about living persons that is unsourced or
203:
192:
572:Learn how and when to remove this message
423:Translational Genomics Research Institute
394:Learn how and when to remove this message
181:Learn how and when to remove this message
163:Learn how and when to remove this message
416:National Human Genome Research Institute
622:
7:
738:Stephan's profile on Big Health Wiki
773:American health care businesspeople
743:Stephan's profile on Business Week
414:, followed by a fellowship at the
14:
778:Carnegie Mellon University alumni
34:This article has multiple issues.
606:development company since 2015.
479:
290:
143:. Please discuss further on the
122:
64:
23:
783:University of Pittsburgh alumni
683:Stephan's profile on Navigenics
453:New England Journal of Medicine
278:, a personal genetics company.
42:or discuss these issues on the
1:
490:biography of a living person
301:biography of a living person
510:must be removed immediately
421:In 2003, Stephan worked at
328:must be removed immediately
809:
718:Elias, Paul (2003-10-02).
696:. aaas.org. Archived from
434:Children's Hospital Boston
408:Carnegie Mellon University
253:Scientist and Entrepreneur
202:
748:Official Navigenics site
412:University of Pittsburgh
753:Official Amnestix site
504:Please help by adding
438:Harvard Medical School
315:Please help by adding
499:references or sources
141:neutral point of view
768:American geneticists
604:peptide therapeutics
321:Contentious material
95:improve this article
584:Stephan co-founded
272:Dietrich A. Stephan
197:Dietrich A. Stephan
99:independent sources
16:American geneticist
679:2011-07-14 at the
521:"Dietrich Stephan"
488:This section of a
343:"Dietrich Stephan"
299:This section of a
630:Grover, Natalie.
611:antisense therapy
582:
581:
574:
556:
404:
403:
396:
378:
304:needs additional
269:
268:
191:
190:
183:
173:
172:
165:
136:with its subject.
116:
115:
86:largely based on
57:
800:
730:
729:
715:
709:
708:
706:
705:
690:
684:
671:
665:
664:
662:
661:
652:. Archived from
646:
640:
639:
627:
577:
570:
566:
563:
557:
555:
514:
506:reliable sources
483:
482:
475:
399:
392:
388:
385:
379:
377:
336:
317:reliable sources
294:
293:
286:
225:
221:
219:
207:
193:
186:
179:
168:
161:
157:
154:
148:
134:close connection
126:
125:
118:
111:
108:
102:
88:routine coverage
68:
67:
60:
49:
27:
26:
19:
808:
807:
803:
802:
801:
799:
798:
797:
758:
757:
734:
733:
717:
716:
712:
703:
701:
692:
691:
687:
681:Wayback Machine
672:
668:
659:
657:
648:
647:
643:
629:
628:
624:
619:
578:
567:
561:
558:
515:
513:
503:
484:
480:
473:
471:Business career
400:
389:
383:
380:
337:
335:
314:
295:
291:
284:
282:Academic career
235:
226:
223:
222:August 25, 1969
217:
215:
198:
187:
176:
175:
174:
169:
158:
152:
149:
138:
127:
123:
112:
106:
103:
92:
77:a press release
69:
65:
28:
24:
17:
12:
11:
5:
806:
804:
796:
795:
790:
785:
780:
775:
770:
760:
759:
756:
755:
750:
745:
740:
732:
731:
710:
685:
666:
641:
636:Endpoints News
621:
620:
618:
615:
580:
579:
487:
485:
478:
472:
469:
402:
401:
325:poorly sourced
298:
296:
289:
283:
280:
267:
266:
259:
258:Known for
255:
254:
251:
247:
246:
241:
237:
236:
227:
213:
209:
208:
200:
199:
196:
189:
188:
171:
170:
130:
128:
121:
114:
113:
81:a news article
72:
70:
63:
58:
32:
31:
29:
22:
15:
13:
10:
9:
6:
4:
3:
2:
805:
794:
793:Living people
791:
789:
786:
784:
781:
779:
776:
774:
771:
769:
766:
765:
763:
754:
751:
749:
746:
744:
741:
739:
736:
735:
727:
726:
721:
714:
711:
700:on 2009-06-14
699:
695:
689:
686:
682:
678:
675:
670:
667:
656:on 2018-06-18
655:
651:
645:
642:
637:
633:
626:
623:
616:
614:
612:
607:
605:
600:
597:
593:
591:
587:
576:
573:
565:
554:
551:
547:
544:
540:
537:
533:
530:
526:
523: –
522:
518:
517:Find sources:
511:
507:
501:
500:
496:
491:
486:
477:
476:
470:
468:
464:
462:
458:
454:
450:
445:
441:
439:
435:
429:
426:
424:
419:
417:
413:
409:
398:
395:
387:
376:
373:
369:
366:
362:
359:
355:
352:
348:
345: –
344:
340:
339:Find sources:
333:
329:
326:
322:
318:
312:
311:
307:
302:
297:
288:
287:
281:
279:
277:
273:
264:
260:
256:
252:
250:Occupation(s)
248:
245:
242:
238:
234:
230:
224:(age 55)
214:
210:
206:
201:
194:
185:
182:
167:
164:
156:
146:
142:
137:
135:
129:
120:
119:
110:
100:
96:
90:
89:
83:
82:
78:
73:This article
71:
62:
61:
56:
54:
47:
46:
41:
40:
35:
30:
21:
20:
723:
713:
702:. Retrieved
698:the original
688:
669:
658:. Retrieved
654:the original
644:
635:
625:
608:
601:
598:
594:
583:
568:
562:October 2021
559:
549:
542:
535:
528:
516:
509:
492:
465:
460:
456:
452:
448:
446:
442:
430:
427:
420:
405:
390:
384:October 2021
381:
371:
364:
357:
350:
338:
327:
310:verification
303:
271:
270:
233:Pennsylvania
177:
159:
153:October 2021
150:
131:
104:
93:Please help
85:
74:
50:
43:
37:
36:Please help
33:
788:1969 births
240:Nationality
84:and may be
75:reads like
762:Categories
704:2017-04-22
660:2018-04-17
617:References
590:David Agus
586:Navigenics
532:newspapers
354:newspapers
276:Navigenics
263:Navigenics
229:Pittsburgh
218:1969-08-25
107:April 2019
39:improve it
725:USA Today
493:does not
306:citations
145:talk page
45:talk page
677:Archived
332:libelous
244:American
97:and add
546:scholar
495:include
449:Science
368:scholar
548:
541:
534:
527:
519:
459:, and
370:
363:
356:
349:
341:
553:JSTOR
539:books
375:JSTOR
361:books
525:news
497:any
457:Cell
436:and
347:news
308:for
212:Born
79:or
764::
722:.
634:.
613:.
463:.
455:,
451:,
440:.
418:.
319:.
231:,
220:)
48:.
728:.
707:.
663:.
638:.
575:)
569:(
564:)
560:(
550:·
543:·
536:·
529:·
512:.
502:.
397:)
391:(
386:)
382:(
372:·
365:·
358:·
351:·
334:.
313:.
216:(
184:)
178:(
166:)
160:(
155:)
151:(
147:.
109:)
105:(
101:.
91:.
55:)
51:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
